Drug intelligence / Profile preview

platelet-rich plasma lysate

Development stage
Unknown
Lead developer
Taichung Veterans General Hospital
Modality
Cell Therapies
Administration
Intralesional
01

Overview

Platelet-rich plasma (PRP) lysate is an autologous or allogeneic biological preparation derived from platelet-rich plasma that has been subjected to a lysis process, such as freeze-thaw cycles, to release the intracellular and alpha-granule contents of platelets. This process results in a concentrated mixture of growth factors, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), and insulin-like growth factor 1 (IGF-1). Unlike standard PRP, the lysate form provides pre-released growth factors for immediate tissue interaction without requiring thrombin activation or intact platelets. It is currently being investigated as an intralesional injection for the treatment of partial-thickness rotator cuff tears, where it aims to stimulate tendon fibroblasts and local tissue cells to promote repair and regeneration.

Other names
platelet-rich plasma lysatePRP lysatelyophilized platelet-rich plasma lysateplatelet lysate

Beyond the preview

Go deeper on platelet-rich plasma lysate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on platelet-rich plasma lysate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call